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ABSTRACT
Objective To examine whether patient level morbidity
based measure of clinical case mix explains variations in
prescribing in general practice.
Design Retrospective study of a cohort of patients
followed for one year.
Setting UK General Practice Research Database.
Participants129 generalpractices,with a total list sizeof
1032072.
Main outcome measures Each patient was assigned a
morbidity group on the bases of diagnoses, age, and sex
using the Johns Hopkins adjusted clinical group case mix
system.Multilevelregressionmodelswereusedtoexplain
variability in prescribing, with age, sex, and morbidity as
predictors.
Results The median number of prescriptions issued
annuallytoapatientis2(90%range0to18).Thenumber
ofprescriptionsissuedtoapatientincreaseswithageand
morbidity. Age and sex explained only 10% of the total
variation in prescribing compared with 80% after
including morbidity. When variation in prescribing was
split between practices and within practices, most of the
variation was at the practice level. Morbidity explained
both variations well.
Conclusions Inclusion of a diagnosis based patient
morbidity measure in prescribing models can explain a
large amount of variability, both between practices and
within practices. The use of patient based case mix
systems may prove useful in allocation of budgets and
therefore should be investigated further when examining
prescribing patterns in general practices in the UK,
particularly for specific therapeutic areas.
INTRODUCTION
The prescribing costs of general practitioners in the
United Kingdom have increased rapidly in recent
years,witha 60%realterms increasein spendingsince
1996 and a 55% increase in the number of items
dispensed. Prescribing by general practitioners now
costs around £7.8b (€9.9; $15.3) a year, about 10% of
theNationalHealthService’sexpenditureinEngland.
1
General practitioners’ prescribing decisions are com-
ing under increasing scrutiny, with considerable
pressure to prescribe cost effectively.
2 The develop-
ment of new drugs, enhanced indications for existing
drugs (such as statins), more rigorous management of
chronic diseases, and the ageing of the population of
England will all continue to increase the cost and
volume of prescribing in primary care.
3 Prescribing
budgetsforprimarycaretrustsarenowallocatedusing
a needs based formula. Budgetary allocations for
prescribing to general practices are, however, still
largelybasedonhistoricalprescribingpatterns.
4When
these patterns do not reflect clinical need, historical
inequities in resource allocations are perpetuated.
To overcome these problems some primary care
trusts are now using needs based models to determine
indicative prescribing budgets for general practices. A
limitationofthesemodelsisthattheyarelargelybased
on the demographic profile of a practice population,
sometimes with a weighting for local characteristics
taken from the census. The models do not generally
contain any direct measure of morbidity within a
practice. Previous research on these models has
generally shown that they are poor predictors of
prescribing costs in practices; and general practices
withhighprescribingcostsoftencomeunderconsider-
able pressure to reduce these costs.
5 Consequently,
general practices that look after populations with
higher burdens of morbidity may be unfairly scruti-
nised or penalised for having high prescribing rates.
Variation in prescribing could be due to differences in
the case mix of patients registered with the general
practices, socioeconomic factors, or inefficient or
inappropriate prescribing. More sophisticated models
to explain these variations are needed. Prescribing
models that incorporate morbidity could be used to
help predict expenditure for budgetary planning and
separate practices that have high prescribing costs
because of a high burden of disease from those that
have high costs because of inefficient prescribing.
Thesemodelscouldalsohelpidentifypracticesthatare
under-treating patients and that have inappropriately
low prescribing rates for their practice’s morbidity
burden.
We used the Johns Hopkins adjusted clinical group
case mix system
6 to investigate how well patient level
morbidity based measures of case mix explain the
variability in prescribing among general practices in
the UK. This is the only case mix system specifically
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used in studies examining variations in primary care
practice.
7-10
METHODS
We obtained data from the UK General Practice
Research Database.
11 General practices participating
inthedatabasefollowsetguidelinesfortherecordingof
clinical and prescribing data and submit anonymised
patientbasedclinicalrecordstothedatabaseatregular
intervals. The accuracy and comprehensiveness of the
data recorded in the database has been documented
previously.
1213Thevariablescollectedbythedatabase
includeage;sex;registrationdetails;medicaldiagnoses
(Read and OXMIS codes) that are part of routine care
or resulting from admissions to hospital, consultations
or emergency care; referrals; laboratory tests; and
prescriptions issued for each patient. Although the
prescriptions issued by specialists are not picked up in
the General Practice Research Database, most pre-
scriptions for chronic disease in the UK are issued by
general practitioners. Data for the year 2001 were
obtainedonlyforpracticesthatmetthe“uptostandard
criteria,” a quality marker set on the basis of internal
consistency of the practice, completeness of long-
itudinal recording, and compliance with the recording
guidelines of the General Practice Research
Database.
14 All practices provided data for the entire
one year period. We excluded patients if they were
registeredwithapracticeforlessthan180days.Usinga
lookuptableweconvertedtheReadandOXMIScodes
to those of the International Classification of Diseases,
ninth revision.
1516
ToconstructthemorbiditygroupsweusedtheJohns
Hopkins adjusted clinical group system software
5 to
initially assign the patients into one of the 81 mutually
exclusive Johns Hopkins adjusted clinical groups, on
the basis of age, sex, and a combination of recorded
diagnoses over a one year period. We then assembled
these groups into six mutually exclusive categories
usingtherangeofdiagnosespertainingtoeachpatient.
These six categories are constructed by the software
according to patients’ expected resource use on the
basis of a nationally representative database of 2
million patients aged less than 65 years in the United
States.Forexample,apatientwithuncomplicatedtype
2 diabetes would be placed in group 2, whereas a
patientwithtype2diabetes,heartfailure,cellulitis,and
chestpainwouldbeplacedingroup5.
6Inthispaperwe
used these six groups to represent patient morbidity
groups, with group 1 being the healthiest patients and
group 6 the sickest. Age was grouped as children
(0-15years),youngadults(16-34),olderadults(35-64),
and adults of pensionable age (≥65 years).
Using the rule of 10 events or observations required
per coefficient estimated in a model and adjusting for
the design factor (using intracluster correlation coeffi-
cient of 0.02 for prescribing and average cluster size of
8000), our study required a total of 14000 events or
observations to estimate the models’ coefficients with
adequateprecision.
17Afterexclusions,thedatasetused
from the General Practice Research Database had
more than sufficient numbers of events or observa-
tions.
Statistical analysis
We used a two level Poisson model with random
intercepts to investigate the association between age,
sex, morbidity, and the number of prescriptions
issued
18 (outcome and predictors were considered at
thepatientlevel),afteraccountingforclusteringwithin
the general practices.
Initially we estimated the extent of variation in
prescribingatthepracticelevelthatisexplainedbythe
predictors, using an adjusted R
2 measure based on a
linear regression model.
19 This was a practice level
analysis in which we considered as the outcome the
mean number of prescriptions issued by each practice
andusedthepracticemeanforageandproportionsfor
each sex and morbidity groups as predictors. To
partition the variation in prescribing at practice and
patient levels we used an R
2 measure derived from a
two level logistic regression with random intercepts.
20
Forthispurposeweconvertedthenumberofprescrip-
tions to a dichotomous response according to whether
or not a patient had received a prescription. As some
informationmaybelostowingtocollapsingnumberof
prescriptions to categories or mean, we carried out a
sensitivity analysis to check the consistency of the
results using another type of R
2 measure estimated
from a two level linear regression model with random
intercepts.
20 We used a square root transformation of
the number of prescriptions issued as the response to
satisfytheassumptionsofnormality.Wecomparedthe
R
2 measures obtained from all three methods across
modelsfitted withno predictors,with ageand sex,and
with age, sex, and morbidity.
Table 1 |Numberofpatientsandannualnumberofprescriptionsissuedbyage,sex,andmorbidity
Variable No of patients
Median %* (90%
range) across
practices
Annual No of
prescriptions
Median of annual
No of prescriptions
(90% range) across
practices
Age group (years):
0-15 202 303 19.0 (15.3 to 25.6) 392 437 1 (0 to 8)
16-34 257 806 24.8 (18.4 to 35.0) 624 181 1 (0 to 10)
35-64 407 051 39.5 (32.7 to 43.7) 1 768 563 2 (1 to 17)
≥65 164 912 15.9 (8.2 to 22.2) 1 840 789 10 (0 to 28)
Sex:
Male 508 545 49.3 (47.4 to 52.3) 1 831 839 1 (0 to 17)
Female 523 527 50.7 (47.7 to 52.6) 2 794 131 3 (0 to 19)
Morbidity:
1 (healthiest) 338 890 31.1 (23.9 to 46.0) 24 648 0
2 140 972 13.7 (8.7 to 20.5) 483 762 2 (0 to 13)
3 251 278 25.0 (20.2 to 28.1) 1 177 099 3 (0 to 15)
4 274 814 27.1 (13.6 to 35.0) 2 602 883 7 (1 to 25)
5 and 6 (sickest) 26 118 2.5 (1.1 to 4.5) 337 578 9 (1 to 36)
Overall 1 032 072 4 625 970 2 (0 to 18)
*Percentage of patients in each age, sex, and morbidity groups were calculated for each practice.
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between patients who had received a prescription and
thosewhohadnotwecalculatedthereceiveroperating
characteristic areas from the logistic model.
21 The
receiver operating characteristic area represents the
proportionofpatientpairsthatiscorrectlyrankedbya
model according to the prescribing status of the
patients.
We used residual plots to investigate assumptions of
normality of residuals required by the multilevel
models. MlwiN v2.02 software
22 and Stata version
9.2
23 were used for the statistical analyses.
RESULTS
Information on age, diagnosis, and prescribing was
complete. Twelve patients were of indeterminate sex
andwereexcludedfromtheanalysis.Afterexclusions,
129 practices with 1032072 patients were eligible for
inclusion. The median time that a patient had been
registered with a general practitioner in 2001 was
11 years. Overall, 49.3% of the patients were male and
50.7%werefemale.Sixtyfourpercentofpatientswere
issued a prescription at least once during 2001. The
median percentage of patients issued a prescription by
the practices was 65% (90% range 11% to 75%). The
median number of prescriptions issued to a patient
across the 129 practices was 2 (0 to 18). The median
total number of prescriptions issued across the 129
practices was 9852 (3508 to 14589).
The number of patients in the two sickest morbidity
groups was small and therefore combined in all
analyses. The results from table 1 show the variations
in the age, sex, and morbidity distribution of patients
acrosspracticesalongwiththenumberofprescriptions
issuedacrossallpracticesforeachofthesegroups.The
sex distribution of the patients was similar across the
practices. The age and morbidity distributions of
patients varied, however, particularly for those in the
oldest age group (≥65 years) and for morbidity groups
4-6. The median number of prescriptions issued
increased with age and morbidity groups and was
higherforfemales.Thenumberofprescriptionsissued
by the practices varied considerably, with the highest
variation occurring in patients aged more than 65 and
in the sickest morbidity groups.
The number of prescriptions issued to a patient was
strongly associated with the patient’s age and morbid-
ity (table 2; P<0.001), increasing steeply with age and
morbidity. Several scenarios are used to illustrate the
relations observed in these models. The expected
numberofprescriptionsforboysandgirlsaged0to15
are estimated to be 1.6 and 2.2, respectively, whereas
the expected numbers for men and women aged 65 or
moreare9.2and12.7.Forthehealthiestboysandgirls
aged 0 to 15 the expected number of prescriptions is
0.05 (same forboth). Thecorresponding valuesforthe
least healthy girls and boys are 6.2 and 6.8. The
expectednumbersofprescriptionsfortheleasthealthy
men and women aged more than 65 are 21.1 and 23.3.
Table 3presentstheresultsontheextentofvariation
explained in prescribing from the practice level
analysis. Adding morbidity explains more of the
variation in prescribing between practices. This result
is supported by the patient level analysis presented in
table 4wherevariationissplitintopracticeandpatient
levels. The inclusion of morbidity explained consider-
ablymoreofthetotalvariabilitythanpatients’ageand
sexalone(80%v10%).Ofthetotalvariation,only0.1%
remained unexplained at the practice level and 19%
remained unexplained at the patient level, after
adjusting for age, sex, and morbidity. When adjusting
for only age and sex the corresponding values are 4%
and 86%. The results also show that most (96%) of the
total variation was within practices. The extent of
variation explained in prescribing based on the
sensitivity analysis was 60% at patient level and 74%
atpracticelevelwhenmorbiditywasincludedand20%
and 6% when only age and sex were included.
The receiver operating characteristic area for a
model with age and sex was 0.648 (95% confidence
interval 0.647 to 0.649), which increased to 0.972
(0.971 to 0.972) when morbidity was included. Thus
morbidity significantly improved the ability of the
model to discriminate between patients who had
received prescriptions and those who had not.
Table 2 |Associationbetweenage,sex,andmorbidityandnumberofprescriptionsissued(results
fromtwolevelPoissonregressionmodelsusingpatientleveldata)
Variable
Rate ratio (95% CI)
Model 2* Model 3†
Age group (years):
0-15 1 1
16-34 1.26 (1.25 to 1.26) 1.13 (1.12 to 1.13)
35-64 2.26 (2.25 to 2.27) 1.85 (1.84 to 1.86)
≥65 5.65 (5.63 to 5.67) 3.38 (3.37 to 3.39)
Sex:
Male 1 1
Female 1.38 (1.37 to 1.38) 1.10 (1.10 to 1.11)
Morbidity:
1( h e a l t h i e s t ) — 1
2 — 43.42 (42.83 to 44.02)
3 — 58.21 (57.53 to 58.89)
4 — 97.03 (95.89 to 98.18)
5 and 6 (sickest) — 134.56 (132.73 to 136.42)
Number of prescriptions issued for each patient was considered as response variable.
*Age and sex.
†Age, sex, and morbidity.
Table 3 |Percentageofvariationbetweenpracticesin
prescribingexplainedusingpracticelevelmeasures
Regression models
Variation (%) explained at
practice level
Model 1: no predictors 0
Model 2: age and sex 4
Model 3: age, sex, and morbidity 57
Mean number of prescriptions issued by each practice was used as
response. Predictors were summarised to express mean (for age) and
percentage (for sex and morbidity) for each practice.
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Patient morbidity explains considerably more of the
variability in prescribing than patients’ age and sex
alone. About 4% of the total variation is at the practice
level and most of the variation is within practices.
Comparison with previous studies
Studieshaveshownthatprescribingingeneralpractice
varies considerably, with threefold to fourfold varia-
tionscommonlyseenevenafterpracticeswithoutlying
prescribing rates are excluded. Statistical models from
thesestudieshavenotincludeddirectmeasuresofcase
mix and have generally explained only a small
proportion of this variation. Other than morbidity
within a practice other factors that could influence
prescribing rates include deprivation; doctors’ knowl-
edge, professional experience, role perception, and
time pressures; the number of doctors in the general
practice; and patients’ expectations of receiving a
prescription and their demands.
24-29
Strengths and limitations
We used data from the General Practice Research
Database, which has been extensively validated and
shown to be of high quality. The practices submitting
informationtothedatabasearereasonablyrepresenta-
tive of the age and sex profile of the UK population,
withsomeunder-representationofinnercitypractices.
The average size of the practices is greater than the
national average.
1330 In contrast with many previous
studies of variation in prescribing, this study used data
at individual patient level rather than an ecological
design. The ecological design has the limitation of
drawinginferencesattheindividualpatientlevelsolely
on the basis of aggregate statistics. This study also
controlled for diagnosis based morbidity groupings
specifically designed for use in primary care when
examining variation in prescribing.
Among the limitations of the study is that the
adjusted clinical group system was developed for use
in the United States and therefore might need some
further adaptation to maximise its utility in the UK. It
has,however,nowbeenusedforanincreasingnumber
ofUKbasedstudies.Finally,theadjustedclinicalgroup
system depends on diagnostic codes recorded by the
generalpractitionersduringconsultations.Differences
in the way that general practitioners record similar
conditionsontheirpracticecomputerscouldintroduce
bias into the estimates of their practices’ morbidity
scores.
Implications for practice
This study used patients’ clinical case mix to explain
variation in general practice prescribing. Including
morbidity in the model considerably improves its
explanatorypowerandthereforeitspotentialutilityfor
monitoring prescribing in general practice and the
allocation of prescribing budgets. With the increasing
use of electronic medical records in general practice,
computerised clinical data for activities such as
measurementofcasemixandassessmentofmorbidity
will become increasingly available.
This study shows how well morbidity helped in
explaining variation in the number of prescriptions
issuedandindeterminingwhichgroupofpatientsare
most likely to receive prescriptions. Each prescrip-
tionissuedmight,however,containseveralitemsand
contain drugs for very different therapeutic areas.
Hence further work is required to investigate the
association between morbidity and total prescribing
volume (measured by the number of items pre-
scribed) and costs and how well morbidity explains
variation in prescribing in specific therapeutic areas.
The use of such patient based measures of case mix
c o u l dt h e nb ee x p l o r e di ns e t t i n gb u d g e t sf o rh e a l t h
services, examining how efficiently health services
are being used, and to produce measures of clinical
performance and quality of care adjusted for case
mix.
Conclusions
Inclusion of a diagnosis based patient morbidity
measure into prescribing models can explain a large
amount of variability at both patient and practice
levels. The use of patient based case mix systems
should be explored further when examining variation
in prescribing patternsbetweenpractices inthe UK,in
particular for prescribing volume and for specific
therapeutic prescribing categories. In the longer term,
case mix systems may prove useful in fairer allocation
of budgets and in the production of case mix adjusted
measures of performance.
Table 4 |Percentageofvariationinprescribingexplainedusingpatientleveldata
Variation Model 1* (%) Model 2† (%) Model 3‡ (%)
Percentage of total variance explained 0 9.7 80.1
Level at which % of total variance was unexplained:
Practice level 3.9 4.1 0.1
Patient level 96.1 86.2 19.0
Prescribing was dichotomised as prescription issued or not issued for each patient.
*No predictors.
†Age and sex.
‡Age, sex, and morbidity group.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Prescribing by UK doctors is under increased scrutiny, with
pressure to prescribe cost effectively
Studies have not explained well the large difference in
prescribing rates between practices
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prescribingmodelscanexplainalargeamountofvariability,
both between and within practices
Patientbasedcasemixsystemsmayhelpintheallocationof
budgets
RESEARCH
page 4 of 5 BMJ | ONLINE FIRST | bmj.comContributors:RZOandAMconceivedthestudyandwrotethemanuscript.
RZO designedand supervised the statisticalanalysis and did someof the
statistical analysis. CO’Sc o n s t r u c t e dt h eg r o u p so nt h eb a s i so ft h e
adjustedclinicalgroup,didthestatisticalanalysis,andcommentedonthe
manuscript. AI extracted the data from the General Practice Research
Databaseand responded to queries about the data.IP actedas anexpert
on the General Practice Research Database and commented on the
manuscript. RZO and CO’S contributed equally to the paper. RZO, CO’S,
and AM are guarantors.
Funding:Thestatisticalanalysiswaspartiallysupportedbyaprimarycare
researcher award from the Department of Health. The work was
undertaken at University College London Hospital/University College
London, which received a proportion of funding from the Department of
Health’s National Institute of Health Research Biomedical Research
Centres funding scheme. The Department of Primary Care and Social
Medicine at Imperial College is supported by the National Institute of
Health Research Biomedical Research Centre scheme.
Competing interests: None declared.
Ethical approval: This study was approved by the scientific and ethical
advisory committee, responsible for the Medicines and Healthcare
products Regulatory Agency General Practice Research Database.
Provenance and peer review: Not commissioned; externally peer
reviewed.
1 ScogginsA,TiessenJ,LingT,RabinovichL.Prescribinginprimarycare,
UnderstandingwhatshapesGPs’prescribingchoicesandhowmight
these be changed. Technical report prepared for the National Audit
Office. Cambridge, UK: RAND Corporation, 2006. www.ppa.org.uk/
pdfs/publications/SMT_V&C_report_200606.pdf.
2 Majeed A, Malcolm L. Unified budgets for primary care groups. BMJ
1999;318:772-6.
3 Prescribing costs in primary care. National Audit Office: London,
2007. www.nao.org.uk/publications/nao_reports/06-07/0607454.
pdf.
4 Majeed A. Allocating budgets for fundholding and prescribing. BMJ
1996;13:1274-5.
5 Favato G, Mariani P, Mills RW, Capone A, Pelagatti M, Pieri V, et al.
ASSET (age/sex standardized estimates of treatment): a research
model to improve the governance of prescribing funds in Italy. PLoS
ONE 2007;2(7):e592.
6 The JohnsHopkins University ACGcase-mix system. 2008. www.acg.
jhsph.edu/.
7 Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care
groups:acategorizationofdiagnosesforresearchandmanagement.
Health Serv Res 1991;26:53-74.
8 Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development
andapplicationofapopulation-orientedmeasureofambulatorycare
case-mix. Med Care 1991;29:452-72.
9 O’SullivanC,OmarRZ,AmblerG,MajeedA.Case-mixandvariationin
specialistreferralsingeneralpractice.BrJGenPract2005;55:529-33.
10 O’Sullivan C, Omar RZ, Forrest CB, Majeed A. Adjusting for case mix
and social class in examining variation in home visits between
practices. Fam Pract 2004;21:355-63.
11 Lawson DH, Sherman V, Hollowell J. The General Practice Research
Database. Scientific and Ethical Advisory Group. QJM
1998;91:445-52.
12 JickH,JickSS,DerbyLE.Validationofinformationrecordedongeneral
practitioner based computerised data resource in the United
Kingdom. BMJ 1991;302:766-8.
13 Hollowell J. The General Practice Research Database: quality of
morbidity data. Popul Trends 1997;87:36-40.
14 General Practice Research Database. 2007. www.gprd.com/.
15 Bindman AB, Forrest CB, Britt H, Crampton P, Majeed A. Diagnostic
scope of and exposure to primary care physicians in Australia, New
Zealand, and the United States: cross sectional analysis of results
from three national surveys. BMJ 2007;334:1261-4.
16 Forrest CB, Majeed A, Weiner JP, Carroll K, Bindman AB. Referral of
children to specialists in the United States and the United Kingdom.
Arch Pediatr Adolesc Med 2003;157:279-85.
17 Machin D, Campbell MJ. Design of studies for medical research.N e w
York: Wiley, 2005.
18 Goldstein H. Multilevel statistical models. 3rd ed. London: Edward
Arnold, 2003.
19 WeisbergS.Appliedlinearregression.3rded.NewYork:Wiley,2005.
20 Snijders TAB, Bosker RJ. Multilevel analysis: an introduction to basic
and advanced multilevel modelling. London: Sage, 1999.
21 HanleyJA,McNeilBJ.Themeaninganduseoftheareaunderareceiver
operating characteristic (ROC) curve. Radiology 1982;143:29-36.
22 Rasbash J,Browne W,Goldstein H,YangM, Plewis I,Healy M, et al.A
users guide to MLwiN, version 2.1. London: Institute of Education,
2000.
23 StataCorp. Stata statistical software: Release 9. College Station, TX:
StataCorp, 2005.
24 Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated
with cost and variation in prescribing among GPs. Fam Pract
2000;17:36-41.
25 WatkinsC,HarveyI,CarthyP,MooreL,RobinsonE,BrawnR.Attitudes
and behaviour of general practitioners and their prescribing costs: a
nationalcrosssectionalsurvey.QualSafHealthCare2003;12:29-34.
26 WebbS, Lloyd M. Prescribing and referral in general practice:a study
of patients’ expectations and doctors’ actions. Br J Gen Pract
1994;44:165-9.
27 BrittenN,UkoumunneO.Theinfluenceofpatients’hopesofreceiving
aprescriptionondoctors’perceptionsandthedecisiontoprescribe:a
questionnaire survey. BMJ 1997;315:1506-10.
28 Cockburn J, Pit S. Prescribing behaviour in clinical practice:
expectations and doctors’ perceptions of patients’ expectations—a
questionnaire study. BMJ 1997;315:520-3.
29 Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G. Social
deprivation and statin prescribing: a cross-sectional analysis using
data from the new UK general practitioner ‘Quality and Outcomes
Framework.’ J Public Health 2007;29:40-7.
30 JickH,JickSS,DerbyLE.Validationofinformationrecordedongeneral
practitioner based computerised data resource in the United
Kingdom. BMJ 1991;302:766-86.
Accepted: 30 April 2008
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 5 of 5